Thermo Scientific™

Imject™ EDC BSA Spin Kit

Catalog number: 77672
Have Questions?
Thermo Scientific™

Imject™ EDC BSA Spin Kit

Catalog number: 77672
Have Questions?
Catalog Number
Unit Size
5 x 2 mg
Price (USD)
Catalog NumberUnit SizePrice (USD)AvailabilityQuantity
776725 x 2 mg
Product Overview
Citations & References
Additional Information
The Thermo Scientific Imject EDC BSA Spin Kit is a package of purified bovine serum albumin carrier protein that enable simple preparation of effective immunogens with amine- or carboxyl-peptide antigens.

BSA is a popular immunogenic carrier protein used for preparation of peptide antigens for immunization and antibody production. Preparations in MES buffer are optimized for peptide-carrier conjugation via the carboxyl-reactive carbodiimide crosslinker called EDC (or EDAC). The Imject EDC Spin Kit includes ready-to-use units of BSA carrier protein, optimized reaction buffers and trouble-free spin desalting columns for immunogen preparation using the EDC method.

Features of the Imject EDC BSA Spin Kit:

Convenient kit—contains lyophilized BSA (in MES buffer), EDC crosslinker and accessories components to easily prepare ready-to-use immunogens for injection
High-yield conjugation—each molecule of 59 lysine residues, 30 to 35 of which have primary amines that are capable of reacting with a conjugation reagent
Validated quality—purified BSA (Fraction V) is ready for use in glutaraldehyde, NHS-ester or EDC crosslinking methods
Compatible solubility—numerous carboxyl groups account for the net negative charge (pI 5.1) of BSA and its high solubility, allowing its use in a broad range of conjugation conditions
Immunogenic—at 67 kDa, BSA is sufficiently large to function as the primary immunogen or it can be used as an irrelevant protein carrier for antibody screening and immunoassays after using KLH as the carrier protein to generate the immune response against the hapten

Carrier proteins are large, complex molecules capable of stimulating an immune response upon injection. Successful production of antibodies specific to small antigens (i.e., peptides or drug compounds) requires that these haptens be covalently conjugated to a larger, more complex molecule (usually a protein) to make them immunogenic. Carrier proteins are chosen based on immunogenicity, solubility, and whether adequate hapten-carrier conjugation can be achieved. Imject BSA is very soluble in aqueous buffers and contains numerous primary amines and carboxyl groups that can be targeted for conjugation with glutaraldehyde, NHS esters, EDC and other crosslinking reagents. Imject BSA is purified and lyophilized in buffers that optimize its stability and solubility for hapten conjugation.

Bovine serum albumin (BSA) is a convenient protein for a variety of uses in the laboratory because, like most abundant plasma proteins, it is very stable and soluble. In addition, the 67 kDa protein is sufficiently large and complex to be fully immunogenic. Consequently, BSA is a popular carrier protein for conjugation to haptens and other weak antigens to make them more immunogenic for the purpose of antibody production. It also provides an independent hapten-carrier protein for microplate and other assay techniques required to screen antibodies produced using KLH or another more immunogenic carrier.

The carbodiimide crosslinker EDC conjugates carboxyl-containing haptens (e.g., C-terminus of peptide antigens) to BSA carrier protein. This method of immunogen preparation is ideal for peptide antigens with few or no aspartic and glutamic acid residues (carboxylates) and lysine residues (primary amines) within the central portion of the primary sequence. Because peptides contain both carboxylate and amines, EDC conjugation results in their becoming variously polymerized and randomly oriented in their linkage to the carrier protein. Typically, this results in a high level of antigen loading on the carrier protein as well as presentation in all possible orientations for antibody production. However, important (desired) epitopes within the antigen peptide sequence may be blocked by EDC-mediated conjugation if those regions contain primary amines (lysine residues) or carboxylates (aspartic and glutamic acid residues). In these cases, either use a homobifunctional amine-reactive crosslinker with the purified BSA in phosphate buffer or synthesize the peptide with a unique terminal cysteine and use a kit with Malemide-Activated BSA to prepare the carrier protein conjugate.

More Product Data
Carrier protein activation and conjugation data for immunogen preparation

Related Products
Imject™ BSA (in PBS)
Imject™ BSA (in MES Buffer)
For Research Use Only. Not for use in diagnostic procedures.


Imject EDC BSA Spin Kit
Product Line

Contents & Storage

Sufficient For: 5 EDC conjugation reactions and complete immunogen preparations, each with up to 2 mg peptide
• Imject BSA (in MES buffer), 5 x 2 mg
• Imject EDC Conjugation Buffer, 30 mL
• EDC Crosslinker, 5 x 10 mg
• Imject Purification Buffer Salts, 5 x 0.84 g
• Zeba Spin Desalting Columns, 7K MWCO, 2 mL, 5 columns

Store at 4°C.


Documents & Downloads


    Frequently asked questions (FAQs)

    Citations & References

    Search citations by name, author, journal title or abstract text